133 related articles for article (PubMed ID: 33508424)
1. CCT3 suppression prompts apoptotic machinery through oxidative stress and energy deprivation in breast and prostate cancers.
Temiz E; Koyuncu İ; Sahin E
Free Radic Biol Med; 2021 Mar; 165():88-99. PubMed ID: 33508424
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of CCT3 promotes cervical cancer progression through FN1.
Dou L; Zhang X
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
[TBL] [Abstract][Full Text] [Related]
4. Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway.
Danni X; Jiangzheng Z; Huamao S; Yinglian P; Changcheng Y; Yanda L
Bioengineered; 2021 Dec; 12(1):7335-7347. PubMed ID: 34612768
[TBL] [Abstract][Full Text] [Related]
5. Molecular chaperone CCT3 supports proper mitotic progression and cell proliferation in hepatocellular carcinoma cells.
Zhang Y; Wang Y; Wei Y; Wu J; Zhang P; Shen S; Saiyin H; Wumaier R; Yang X; Wang C; Yu L
Cancer Lett; 2016 Mar; 372(1):101-9. PubMed ID: 26739059
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA CCT3 is a unique molecular marker in bladder cancer.
Luo L; Xie Q; Wu Y; Li P; Qin F; Liao D; Wang K
BMC Cancer; 2023 Oct; 23(1):977. PubMed ID: 37833621
[TBL] [Abstract][Full Text] [Related]
7. Restraint of chaperonin containing T-complex protein-1 subunit 3 has antitumor roles in non-small cell lung cancer via affection of YAP1.
Shi H; Zhang Y; Wang Y; Fang P; Liu Y; Li W
Toxicol Appl Pharmacol; 2022 Mar; 439():115926. PubMed ID: 35182550
[TBL] [Abstract][Full Text] [Related]
8. Chaperonin containing TCP-1 subunit 3 is critical for gastric cancer growth.
Li LJ; Zhang LS; Han ZJ; He ZY; Chen H; Li YM
Oncotarget; 2017 Dec; 8(67):111470-111481. PubMed ID: 29340068
[TBL] [Abstract][Full Text] [Related]
9. Suppression of CCT3 inhibits the proliferation and migration in breast cancer cells.
Xu G; Bu S; Wang X; Zhang H; Ge H
Cancer Cell Int; 2020; 20():218. PubMed ID: 32518527
[TBL] [Abstract][Full Text] [Related]
10. Suppression of CCT3 inhibits melanoma cell proliferation by downregulating CDK1 expression.
Liu W; Zhang X; Chen C; Li Y; Yang C; Han Z; Jiang G; Liu Y
J Cancer; 2022; 13(6):1958-1971. PubMed ID: 35399722
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA NEAT1 promotes human glioma tumor progression via miR-152-3p/CCT6A pathway.
Li B; Lu X; Ma C; Sun S; Shu X; Wang Z; Sun W
Neurosci Lett; 2020 Jul; 732():135086. PubMed ID: 32454145
[TBL] [Abstract][Full Text] [Related]
12. Identification of CCT3 as a prognostic factor and correlates with cell survival and invasion of head and neck squamous cell carcinoma.
Wang Y; Liu P; Zhang Z; Wang J; Cheng Z; Fan C
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34505628
[TBL] [Abstract][Full Text] [Related]
13. CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.
Liu Y; Zhang X; Lin J; Chen Y; Qiao Y; Guo S; Yang Y; Zhu G; Pan Q; Wang J; Sun F
Cell Death Dis; 2019 Sep; 10(9):644. PubMed ID: 31501420
[TBL] [Abstract][Full Text] [Related]
14. Suppression of
Shi X; Cheng S; Wang W
Oncol Lett; 2018 Jun; 15(6):9202-9208. PubMed ID: 29805652
[TBL] [Abstract][Full Text] [Related]
15. Suppression of CCT3 Inhibits Tumor Progression by Impairing ATP Production and Cytoplasmic Translation in Lung Adenocarcinoma.
Chen S; Tian Y; Ju A; Li B; Fu Y; Luo Y
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409343
[TBL] [Abstract][Full Text] [Related]
16. High expression of chaperonin-containing TCP1 subunit 3 may induce dismal prognosis in multiple myeloma.
Qian T; Cui L; Liu Y; Cheng Z; Quan L; Zeng T; Huang W; Dai Y; Chen J; Liu L; Chen J; Pang Y; Wu G; Ye X; Shi J; Fu L; Si C
Pharmacogenomics J; 2020 Aug; 20(4):563-573. PubMed ID: 31902948
[TBL] [Abstract][Full Text] [Related]
17. Interactions of subunit CCT3 in the yeast chaperonin CCT/TRiC with Q/N-rich proteins revealed by high-throughput microscopy analysis.
Nadler-Holly M; Breker M; Gruber R; Azia A; Gymrek M; Eisenstein M; Willison KR; Schuldiner M; Horovitz A
Proc Natl Acad Sci U S A; 2012 Nov; 109(46):18833-8. PubMed ID: 23112166
[TBL] [Abstract][Full Text] [Related]
18. Current understanding on the role of CCT3 in cancer research.
Liu W; Lu Y; Yan X; Lu Q; Sun Y; Wan X; Li Y; Zhao J; Li Y; Jiang G
Front Oncol; 2022; 12():961733. PubMed ID: 36185198
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of MicroRNA miR-101-3p on prostate cancer progression by regulating Cullin 4B (CUL4B) and PI3K/AKT/mTOR signaling pathways.
Gu Z; You Z; Yang Y; Ding R; Wang M; Pu J; Chen J
Bioengineered; 2021 Dec; 12(1):4719-4735. PubMed ID: 34338146
[TBL] [Abstract][Full Text] [Related]
20. Miles to go (mtgo) encodes FNDC3 proteins that interact with the chaperonin subunit CCT3 and are required for NMJ branching and growth in Drosophila.
Syed A; Lukacsovich T; Pomeroy M; Bardwell AJ; Decker GT; Waymire KG; Purcell J; Huang W; Gui J; Padilla EM; Park C; Paul A; Pham TBT; Rodriguez Y; Wei S; Worthge S; Zebarjedi R; Zhang B; Bardwell L; Marsh JL; MacGregor GR
Dev Biol; 2019 Jan; 445(1):37-53. PubMed ID: 30539716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
